Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

ESI Lederle launches generic acyclovir

April 29, 1997

MDL-101731 shows potent antiviral activity in vitro

April 29, 1997

Pharmacia & Upjohn discloses new antimicrobial agents

April 29, 1997

Matrix Pharmaceutical announces marketing partner for AccuSite in Spain and Portugal

April 28, 1997

VIMRx completes phase I studies for VIMRxyn

April 28, 1997

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Roussel Uclaf claims new cephalosporins

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...